Type 1 diabetes, rheumatoid arthritis, and cancer are just some of the disorders associated with specific genes not “turning on” and “turning off” as they should. By using new CRISPR/Cas9 genome editing technology, in a recent paper in Nature Communications, McGill University researchers have described a new technique that scientists across the world can potentially use to explore novel ways of treating diseases associated with dysregulation in DNA methylation.
Category:
Published on: 9 Nov 2021
Montreal, October 20, 2021 - A person who receives a life-changing diagnosis of dementia has many questions. What changes can I expect to my daily routine? How long can I remain independent? How will this affect my relationship with my loved ones?
Category:
Published on: 20 Oct 2021
Bacteria can store extra resources for the lean times. It’s a bit like keeping a piggy bank or carrying a backup battery pack. One important reserve is known as cyanophycin granules, which were first noticed by an Italian scientist about 150 years ago. He saw big, dark splotches in the cells of the blue-green algae (cyanobacteria) he was studying without understanding either what they were or their purpose.
Category:
Published on: 14 Oct 2021
A team of international researchers, including McGill Professor Stéphane Laporte, have discovered the working mechanism of potential drug targets for various diseases such as cancer, rheumatoid arthritis, and even COVID-19. The findings published in Molecular Cell uncover the inner workings of cell receptors that are involved in cancer progression and inflammatory diseases.
Category:
Published on: 27 Sep 2021
McGill University co-editors Drs. Serge Gauthier, Pedro Rosa-Neto, José A. Morais and Ms. Claire Webster deliver the World Alzheimer Report 2021, 'Journey through the diagnosis of dementia'.
Category:
Published on: 22 Sep 2021
Mothers who smoke are more likely to deliver smaller babies even after a full-term pregnancy, increasing the risks of birth defects and neurological disorders later in life, say researchers from McGill University. The team of researchers, which includes Assistant Professor Michael Dahan and Ido Feferkorn of the McGill University Health Care Center, examined the effects of smoking on more than nine million deliveries in the Unites States over 11 years, one of the largest studies to date.
Category:
Published on: 20 Sep 2021
McGill University researchers identify proteins that drive cancer stem cells. Targeting and supressing a particular protein called galectin1 could provide a more effective treatment for glioblastoma, in combination with radiation therapy.
Due to its resistance to therapy, glioblastoma is the most common and aggressive cancerous brain tumour in adults. It grows fast and spreads quickly. While treatments such as surgery, radiation, and chemotherapy can help ease symptoms for a few months, in most cases tumour cells regrow after treatment and the cancer recurs.
Category:
Published on: 31 Aug 2021
Dear Faculty of Medicine and Health Sciences Colleagues,
Category:
Published on: 30 Jun 2021
Today, at l'Université du Québec à Trois-Rivières, the Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry announced investments of more than $635 million for science, research, and engineering in Canada.
Category:
Published on: 15 Jun 2021
Vancouver, BC -- The Government of Canada and the Terry Fox Research Institute (TFRI) have jointly signed a Contribution Agreement which opens the door for the Marathon of Hope Cancer Centres Network to begin operating.
Published on: 9 Jun 2021
While previous research early in the pandemic suggested that vitamin D cuts the risk of contracting COVID-19, a new study from McGill University finds there is no genetic evidence that the vitamin works as a protective measure against the coronavirus.
"Vitamin D supplementation as a public health measure to improve outcomes is not supported by this study. Most importantly, our results suggest that investment in other therapeutic or preventative avenues should be prioritized for COVID-19 randomized clinical trials," say the authors.
Category:
Published on: 4 Jun 2021
By David McFadden
Listed by the World Health Organization among the ten leading causes of medical disability worldwide, the severity of obsessive-compulsive disorder (OCD) is at a level on par with cancer. This prevalent disorder is characterized by highly distressing intrusive thoughts and repeated compulsive behaviours such as washing or checking.
Category:
Published on: 3 Jun 2021
A team of researchers at the RI-MUHC found two cellular pathways involved in TNBC tumour development and a promising targeted combination therapy
Source: RI-MUHC
Published on: 3 Jun 2021
PLOS ONE publishes foundational article on the Biobanque québécoise de la COVID-19 (BQC19)
Published on: 20 May 2021
Dear members of our Faculty community,
Our world has changed since the onset of the COVID-19 pandemic, yet we have persevered to continue to offer world-class education and conduct leading research. Indeed, I am immensely proud of our contributions.
Category:
Published on: 19 May 2021
Pages
